CH201834A - Process for the preparation of a 7-dehydrosterol. - Google Patents
Process for the preparation of a 7-dehydrosterol.Info
- Publication number
- CH201834A CH201834A CH201834DA CH201834A CH 201834 A CH201834 A CH 201834A CH 201834D A CH201834D A CH 201834DA CH 201834 A CH201834 A CH 201834A
- Authority
- CH
- Switzerland
- Prior art keywords
- derivative
- reducing agent
- ether
- dehydrositosterol
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims description 8
- ICFXJOAKQGDRCT-UHFFFAOYSA-N (24R)-24-ethyl-cholest-5-en-3beta-ol-7-one Natural products C1CC(O)CC2=CC(=O)C3C4CCC(C(C)CCC(CC)C(C)C)C4(C)CCC3C21C ICFXJOAKQGDRCT-UHFFFAOYSA-N 0.000 claims description 6
- UOELMDIOCSFSEN-FVZZCGLESA-N 7-Dehydrositosterol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)C=C[C@H](C)C(C)C)=CC=C1C[C@@H](O)CCC1=C.C1[C@@H](O)CCC2(C)C(CC[C@@]3([C@@H]([C@H](C)C=C[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 UOELMDIOCSFSEN-FVZZCGLESA-N 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229950005143 sitosterol Drugs 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 claims description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims description 2
- 235000015500 sitosterol Nutrition 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 2
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- PBWOIPCULUXTNY-UHFFFAOYSA-N Sitosterylacetat Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 PBWOIPCULUXTNY-UHFFFAOYSA-N 0.000 description 1
- UOLJGJFAVGOXAH-UHFFFAOYSA-N Stigmastanol-acetat Natural products C1CC2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 UOLJGJFAVGOXAH-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- DAMJCWMGELCIMI-UHFFFAOYSA-N benzyl n-(2-oxopyrrolidin-3-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC1CCNC1=O DAMJCWMGELCIMI-UHFFFAOYSA-N 0.000 description 1
- PBWOIPCULUXTNY-LBKBYZTLSA-N beta-sitosterol 3-O-acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 PBWOIPCULUXTNY-LBKBYZTLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Darstellung eines 7-Dehydrosterins. Es wurde gefunden, dass man 7-Oxosito- sterin in 7 - Dehydrositosterin umwandeln kann, wenn man ein Acylderivat des 7-Oxo- sitosterins durch Einwirken eines als mildes Reduktionsmittel wirkenden Metallalkoholats, z.
B. eines Alkoholats eines Erdmetalles, im besonderen von Aluminium, unter Erhaltung der Doppelbindung in 7-Oxysitosterin über führt und dieses zu einem Diacylderivat ver- estert, aus diesem durch<B>DA</B> rhitzen dien Aeyl- rest in 7-Stellung in Form von Säure ab- spaltet und das dabei erhaltene Monoacyl- derivat verseift.
Die bei der Abspaltung ent stehende neue Doppelbindung befindet sich in konjugierter Stellung zu der in 5,6-Stellung des Ausgangsstoffes bereits vorhanden ge- wesenen Doppelbindung.
In dem die Keto- gruppe enthaltenden Ring B des Sitosterins vollziehen sich die oben beschriebenen Um setzungen nach dem folgenden Reaktions schema:
EMI0001.0035
Das so erhältliche, bisher noch nicht be kannte 7 - Dehydrositosterin bildet Kristalle vom Schmelzpunkt 148 bis<B>150'.</B> Es ist fäll bar mit Digitonin, schwer löslich in Methyl alkohol, leicht löslich in Äther. Es hat ein Absorptionsspektrum, das dem des Ergo sterins fast gleich ist. Es soll als Ausgangs material für die Herstellung antirhachitisch aktiver Produkte Anwendung finden.
Beispiel: Zur Gewinnung von 7-Oxositosterin wer den 100 g Sitosterin-acetat in 5 Liter heissem Eisessig gelöst, nach dem Abkühlen auf 50 bis 60 mit einer Auflösung von 90g Chrom säureanhydrid in Eisessig versetzt und 5 Stunden bei 50 bis 60 gehalten. Die Eis essiglösung wird bei vermindertem Druck auf etwa 300 cm' eingeengt, der Rückstand mit Äther extrahiert und der Ätherextrakt durch Ausschütteln mit Natriumca.rbonat- lösung von sauren Anteilen befreit. Der Ätherextrakt wird auf ein kleines Volumen eingeengt und mit Methanol bis zum Kri- stallisationsbeginn versetzt.
Das Rohprodukt wird aus Äther-Methanol umkristallisiert. Das 7-Oxo-sitosterinacetat schmilzt bei 154 , kristallisiert in Blättchen, ist leicht löslich in :Äther und Aceton, schwer löslich in Methyl alkohol.
Zur L: mwandlung in 7-Oxy -sitosterin wer den 25 g 7-Oxo-sitosterinacetat in 250 cm" trockenem Isopropylalkohol gelöst, 10 g Alu miniumisopropylat hinzugegeben und 5 Stun den am Rückflusskühler zum Sieden erhitzt.
Nach beendeter Reduktion unter gleich zeitiger Abspaltung der Acetylgruppe giesst man die Lösung in etwa 3 Liter 0, 5 % ige wässrige Natronlauge und filtriert das flockig abgeschiedene Reduktionsprodukt ab, löst den Niederschlag in Äther, filtriert abermals, dampft die ätherische Lösung auf etwa 100 cm' und versetzt mit. 300 ein' Petrol- äther. Dabei scheidet sich das rohe 7-Oxy-sito- sterin in Form von kleinen Gallertkugeln ab.
Zur Darstellung von 7-Oxv-sitosterin-di- benzoat werden 20 g 7-Oxysitosterin in 150 cm@ Pyridin gelöst, mit ?5 cm' Benzoyl- chlorid versetzt und 15 Stunden bei Zimmer temperatur stehen gelassen. Die Pyridin- lösung wird mit Äther-Wasser verdünnt, der Ätherextrakt mittels verdünnter Salzsäure von Pyridin befreit, säurefrei gewaschen, über Natriumsulfat getrocknet. und auf etwa 50 cm eingeengt.
Versetzt man die ätherische Lösung bis zur beginnenden Trübung mit Methanol, scheidet sich das Dibenzoat in fei nen Nadeln ab. Das 7-Oxy-sitosterin-diben- zogt schmilzt nach dem Umkristallisieren aus Äther - Methanol oder Aceton - 31ethanol bei 15511.
Zur Uniu-andlung in das 7-Dehydro-sito- sterinbenzoat wird 7-Oxv-sitosterin-dibenzoat in Portionen von je l@ g im Hochvakuum 1/2 Stunde auf<B>1.75</B> erhitzt. Dabei gehen Benzoesäure und ölige Anteile über. Der Erhitzungsrückstand wird in Äther gelöst. die ätherische Lösung auf ein kleines Vo lumen eingeengt. und mit Methanol bis zur Trübung versetzt.
Das abgeschiedene Mono benzoat wird zur weiteren Reinigung aus Äther-Methylalkohol umkristallisiert. Das 7 Dehvdrositosterin-benzoat kristallisiert in Na deln und schmilzt bei 144 bis 146 .
Zur Gewinnung des 7-Dehydro-sitosterins wird 1 g 7 - Dehydro-sitosterin-benzoat in 1.0 cm:' heissem Benzol gelöst und bei Siede hitze mit 30 cm' 5%iger Natriummethylat- lösung versetzt, dann destilliert man das Lö sungsmittel bis zum Kristallisationsbeginn ,i h. Zur weiteren Reinigung kristallisiert man aus -#-tlier-Jlethylalkohol um. Das 7-Dehy cIro- sitosterin kristallisiert in grossen Blättchen.
schmilzt bei 148 bis 150 , ist leicht löslich in Äther, sehr schwer löslich in Methyl- oder Äthylalkohol. Es ist fällbar mit Digitonin, beim Versetzen einer Chloroformlösung mit Antimontrichlorid tritt sofort Rotfärbung ein, die nach einigem Stehen in Blau über geht. Das Absorptionsspektrum ist dem des Ergosterins fast. gleich.
Process for the preparation of a 7-dehydrosterol. It has been found that 7-oxositosterol can be converted into 7-dehydrositosterol if an acyl derivative of 7-oxositosterol is acted upon by a metal alcoholate acting as a mild reducing agent, e.g.
B. converts an alcoholate of an earth metal, in particular of aluminum, into 7-oxysitosterol while maintaining the double bond and esterifies this to a diacyl derivative, from which the aeyl radical in 7- Position in the form of acid is split off and the resulting monoacyl derivative is saponified.
The new double bond formed during the cleavage is in the conjugated position to the double bond that was already present in the 5,6-position of the starting material.
In ring B of the sitosterol containing the keto group, the reactions described above take place according to the following reaction scheme:
EMI0001.0035
The previously unknown 7-dehydrositosterol which is obtainable in this way forms crystals with a melting point of 148 to 150 '. It can be precipitated with digitonin, sparingly soluble in methyl alcohol, easily soluble in ether. It has an absorption spectrum that is almost the same as that of ergonene. It should be used as a starting material for the manufacture of anti-inflammatory products.
Example: To obtain 7-oxositosterol, whoever dissolved 100 g of sitosterol acetate in 5 liters of hot glacial acetic acid, after cooling to 50 to 60, added 90 g of chromic anhydride in glacial acetic acid and held at 50 to 60 for 5 hours. The glacial acetic acid solution is concentrated to about 300 cm 'under reduced pressure, the residue is extracted with ether and the ether extract is freed from acidic components by shaking with sodium carbonate solution. The ether extract is concentrated to a small volume and methanol is added until the start of crystallization.
The crude product is recrystallized from ether-methanol. The 7-oxositosterol acetate melts at 154, crystallizes in flakes, is easily soluble in: ether and acetone, sparingly soluble in methyl alcohol.
To convert to 7-oxy-sitosterol, 25 g of 7-oxositosterol acetate are dissolved in 250 cm "of dry isopropyl alcohol, 10 g of aluminum isopropylate are added and the mixture is heated to the boil for 5 hours on the reflux condenser.
After the reduction is complete and the acetyl group is split off at the same time, the solution is poured into about 3 liters of 0.5% aqueous sodium hydroxide solution and the flaky reduction product is filtered off, the precipitate is dissolved in ether, filtered again, the ethereal solution is evaporated to about 100 cm ' and offset with. 300 a petroleum ether, during which the crude 7-oxy-sitsterin is deposited in the form of small gelatinous balls.
To prepare 7-oxysitosterol dibenzoate, 20 g of 7-oxysitosterol are dissolved in 150 cm of pyridine, 5 cm of benzoyl chloride are added and the mixture is left to stand for 15 hours at room temperature. The pyridine solution is diluted with ether-water, the ether extract is freed from pyridine using dilute hydrochloric acid, washed acid-free and dried over sodium sulphate. and narrowed to about 50 cm.
If the ethereal solution is mixed with methanol until it starts to become cloudy, the dibenzoate separates out in fine needles. After recrystallization from ether - methanol or acetone - 31ethanol, the 7-oxy-sitosterol-diben- delt melts at 15511.
To convert it into the 7-dehydrositosterol benzoate, 7-oxv-sitosterol dibenzoate is heated in portions of 1 g each in a high vacuum to 1.75 for 1/2 hour. Benzoic acid and oily components go over. The heating residue is dissolved in ether. the essential solution is concentrated to a small volume. and mixed with methanol until cloudy.
The deposited monobenzoate is recrystallized from ether methyl alcohol for further purification. The dehydrositosterol benzoate crystallizes in needles and melts at 144 to 146.
To obtain the 7-dehydrositosterol, 1 g of 7-dehydrositosterol benzoate is dissolved in 1.0 cm: 'of hot benzene and 30 cm of 5% sodium methylate solution is added at boiling point, then the solvent is distilled up to Start of crystallization, i h. For further purification, one crystallizes from - # - tlier-ethyl alcohol. The 7-Dehy cirositosterol crystallizes in large leaflets.
melts at 148 to 150, is easily soluble in ether, very sparingly soluble in methyl or ethyl alcohol. It can be precipitated with digitonin; when antimony trichloride is added to a chloroform solution, it turns red immediately, which turns blue after standing for a while. The absorption spectrum is almost that of ergosterol. equal.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201834X | 1935-03-20 | ||
| CH194451T | 1936-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH201834A true CH201834A (en) | 1938-12-15 |
Family
ID=25722672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH201834D CH201834A (en) | 1935-03-20 | 1936-03-11 | Process for the preparation of a 7-dehydrosterol. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH201834A (en) |
-
1936
- 1936-03-11 CH CH201834D patent/CH201834A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH201834A (en) | Process for the preparation of a 7-dehydrosterol. | |
| DE1668598C2 (en) | 1β-Hydroxy-4- (carboxymethyl) -5-oxo-7aβ-methyl-3aα, 4β, 5,6,7,7a-hexahydroindane, its 1β-acetoxy-lactone, salts and processes for their preparation | |
| AT160572B (en) | Process for the preparation of unsaturated oxyketones of the cyclopentanopolydrophenanthrene series or their derivatives. | |
| DE1793825C3 (en) | 2- (6'-substituted-2'-naphthyl) propionic acid derivatives and their preparation | |
| DE1219019B (en) | Process for the production of trans-decen- (2) -one- (9) -aeure- (1) | |
| DE934103C (en) | Process for the production of cyclooctylated alkyl acetic acids with a strong cholagogue effect | |
| AT164549B (en) | Process for the production of sterol degradation products | |
| AT203474B (en) | Process for the preparation of α, β-unsaturated aldehydes | |
| DE897704C (en) | Process for the production of A4,5; 16,17-pregna-dien-ol- (21) -dione- (3,20) -abkoemmlingen | |
| DE873842C (en) | Process for the preparation of unsaturated ketones of the cyclopentanopolyhydrophenanthrene series | |
| AT270884B (en) | Process for the preparation of new 4,6-pregnadiene derivatives | |
| DE892447C (en) | Process for the preparation of dicyclohexyl ethane compounds | |
| DE954248C (en) | Process for the preparation of new tricyclic ketones | |
| AT239455B (en) | Process for the preparation of new 17α-acyloxy-6-methyl-16-methylenpregna-4,6-diene-3,20-diones | |
| DE843407C (en) | Process for the preparation of oxyhydrophenanthrencarboxylic acids and their derivatives | |
| DE820307C (en) | Process for the preparation of new naphthylpropionic acids and their functional derivatives | |
| AT160829B (en) | Process for the preparation of unsaturated 3-oxo compounds of steroids or their enol derivatives. | |
| AT216156B (en) | Process for the preparation of polyhydrophenanthrene compounds | |
| DE879098C (en) | Process for the preparation of ring-substituted saturated or unsaturated androstanol- (17) -onen- (3) or their 17-derivatives | |
| AT215087B (en) | Process for the production of carotenoids | |
| AT162906B (en) | Process for the preparation of derivatives of the cyclopentano-polyhydro-phenantren- or the polyhydro-chrysen series | |
| AT218181B (en) | Process for the production of new lactones in the steroid range | |
| AT219204B (en) | Process for the preparation of 3-alkoxy-19-nor-δ <2,5 (10)> -androstadien-17-one | |
| CH194451A (en) | Process for the preparation of a 7-dehydrosterol. | |
| CH322615A (en) | Process for the preparation of 1-keto-4-oxy-polyhydrophenanthrenes |